The furosemide stress test (FST) is a safe and easy assessment of renal tubular function. Other factors, such as mean arterial pressure (MAP), which may influence the success rates of the FST, have not been well defined.
Objective
To evaluate the relationship between MAP and success rates of the FST in critically ill patients.
Methods
Retrospective, single-center, institutional review board (IRB)-approved cohort study. Critically ill adult patients given at least one dose of intravenous (IV) furosemide (≥1-1.5 mg/kg) were included. Primary outcome was whether a MAP ≥ 75 mm Hg would equate to a higher FST success rate. Secondary outcome was the success rates of patient on one or more vasopressors.
Results
Of 225 patients, 88 (39.1%) had a successful FST. In patients with a MAP ≥ 75 mm Hg, 60 out of 104 (57.7%) had a successful FST compared to 28 out of 121 (23.1%) of patients who had a MAP < 75 mm Hg (odds ratio [OR], 4.53, 95% CI, 2.55-8.74, P < 0.001). Patients on vasopressors at the time of the furosemide dose had lower rates of success compared to those not on vasoactive agents (30.4% versus 68.2%, p = 0.026). Limitations of this study include its retrospective design and reliance on documented urine output.
Conclusion and Relevance
Patients with a MAP ≥ 75 mm Hg were significantly more likely to have a successful FST compared to those with a MAP < 75 mm Hg. This represents the first report of factors that may influence FST success rates.
Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(suppl 1):1-138. doi:10.1038/kisup.2012.1.
2.
ChawlaLSDavisonDLBrasha-MitchellE, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17(5):R207. doi:10.1186/cc13015.
3.
CocaAAllerCReinaldo SánchezJ, et al. Role of the furosemide stress test in renal injury prognosis. Int J Mol Sci. 2020;21(9):3086. doi:10.3390/ijms21093086.
4.
HuangXDorhout MeesEVosP, et al. Everything we always wanted to know about furosemide but were afraid to ask. Am J Physiol Renal Physiol. 2016;310(10):F958-F971. doi:10.1152/ajprenal.00476.2015.
5.
CaseJKhanSKhalidRKhanA.Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730. doi:10.1155/2013/479730.
6.
MatsuuraRKomaruYMiyamotoY, et al. Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels. Ann Intensive Care. 2018;8(1):8. doi:10.1186/s13613-018-0355-0.
7.
ChenJJChangCHHuangYT, et al. Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis. Crit Care. 2020;24(1):202. doi:10.1186/s13054-020-02912-8.
ParikhCRMansourSG.Perspective on clinical application of biomarkers in AKI. J Am Soc Nephrol. 2017;28(6):1677-1685. doi:10.1681/ASN.2016101127.
10.
QaviAHKamalRSchrierRW.Clinical use of diuretics in heart failure, cirrhosis, and nephrotic syndrome. Int J Nephrol. 2015;2015:975934. doi:10.1155/2015/975934.
Claure-Del GranadoRMehtaRL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17(1):109. doi:10.1186/s12882-016-0323-6.
13.
PowellTCWarnockDG.The furosemide stress test and predicting AKI outcomes. J Am Soc Nephrol. 2015;26(8):1762-1764. doi:10.1681/ASN.2014121160.
14.
RewaOGBagshawSMWangX, et al. The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: a multicenter, prospective, observational study. J Crit Care. 2019;52:109-114. doi:10.1016/j.jcrc.2019.04.011.
15.
KoynerJLDavisonDLBrasha-MitchellE, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26(8):2023-2031. doi:10.1681/ASN.2014060535.
16.
KatoRPinskyMR.Personalizing blood pressure management in septic shock. Ann Intensive Care. 2015;5(1):41. doi:10.1186/s13613-015-0085-5.
17.
PoukkanenMWilkmanEVaaraST, et al. Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care. 2013;17(6):R295. doi:10.1186/cc13161.
18.
MomanRNOstbySAAkhoundiA, et al. Impact of individualized target mean arterial pressure for septic shock resuscitation on the incidence of acute kidney injury: a retrospective cohort study. Ann Intensive Care. 2018;8(1):124. doi:10.1186/s13613-018-0468-5.
19.
BusseLWOstermannM.Vasopressor therapy and blood pressure management in the setting of acute kidney injury. Semin Nephrol. 2019;39(5):462-472. doi:10.1016/j.semnephrol.2019.06.006.
20.
EvansLRhodesAAlhazzaniW, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181-1247. doi:10.1007/s00134-021-06506-y.
21.
LumlertgulNPeerapornratanaSTrakarnvanichT, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care. 2018;22(1):101. doi:10.1186/s13054-018-2021-1.
22.
BadinJBoulainTEhrmannS, et al. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care. 2011;15(3):R135. doi:10.1186/cc102530.
23.
AsareK.Management of loop diuretic resistance in the intensive care unit. Am J Health Syst Pharm. 2009;66(18):1635-1640. doi:10.2146/ajhp090068.
24.
BosmaRJKrikkenJAHoman van der HeideJJ, et al. Obesity and renal hemodynamics. Contrib Nephrol. 2006;151:184-202. doi: 10.1159/000095329.
25.
KwakernaakAJTentHRookMKrikkenJANavisG.Renal hemodynamics in overweight and obesity: pathogenetic factors and targets for intervention. Expert Rev Endocrinol Metab. 2007;2(4):539-552. doi:10.1586/17446651.2.4.539.
26.
MarianoFMellaAVincentiMBianconeL.Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug. J Nephrol. 2019;32(6):883-893. doi:10.1007/s40620-019-00614-1.
27.
BellomoRGiantomassoDD.Noradrenaline and the kidney: friends or foes?Crit Care. 2001;5(6):294-298. doi:10.1186/cc1052.
28.
BourgoinALeoneMDelmasAGarnierFAlbanèseJMartinC.Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med. 2005;33(4):780-786. doi:10.1097/01.ccm.0000157788.20591.23.
RussellJAWalleyKRSingerJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887. doi:10.1056/NEJMoa067373.
